EMN27 A phase 2 study of Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis Read More
EMN22 Phase 2 study of daratumumab monotherapy in previously untreated patients with stage 3B light chain (AL) amyloidosis The Alcaeus Study Read More
EMN23 A retrospective observational multicenter study on the management and outcome of patients with systemic AL amyloidosis in Europe Read More
